See also this year's filing and all EDGAR filings for this company.
PDF Report 0000849636_2019_RespireRx_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000849636')"} |
Graph
Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 121,076 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 3,114 |
4 | LiabilitiesCurrent | 5,857,445 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 1,488,238 |
9 | ResearchAndDevelopmentExpense | 688,286 |
10 | remainder_Expenses | 302,625 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -112,641 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 124,190 |
1 | Liabilities | 5,857,445 |
2 | Expenses | 2,479,149 |
3 | Revenues | 0 |
4 | StockholdersEquity | -5,733,255 |
5 | NetIncome | -2,591,790 |
6 | ComprehensiveNetIncome | -2,591,790 |
7 | BaseVar | 4,286,712 |
8 | EconomicCapitalRatio | -4.16 |